Masimo Gross Profit 2012-2025 | MASI
Masimo annual/quarterly gross profit history and growth rate from 2012 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Masimo gross profit for the quarter ending September 30, 2025 was $0.231B, a 8.72% increase year-over-year.
- Masimo gross profit for the twelve months ending September 30, 2025 was $1.076B, a 21.11% increase year-over-year.
- Masimo annual gross profit for 2024 was $1.004B, a 0.09% increase from 2023.
- Masimo annual gross profit for 2023 was $1.004B, a 5.22% decline from 2022.
- Masimo annual gross profit for 2022 was $1.059B, a 30.97% increase from 2021.
|
Masimo Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $1,004 |
| 2023 | $1,004 |
| 2022 | $1,059 |
| 2021 | $808 |
| 2020 | $743 |
| 2019 | $629 |
| 2018 | $575 |
| 2017 | $522 |
| 2016 | $478 |
| 2015 | $410 |
| 2014 | $391 |
| 2013 | $359 |
| 2012 | $326 |
| 2011 | $294 |
|
Masimo Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-09-30 | $231 |
| 2025-06-30 | $233 |
| 2025-03-31 | $234 |
| 2024-12-31 | $378 |
| 2024-09-30 | $212 |
| 2024-06-30 | $207 |
| 2024-03-31 | $207 |
| 2023-12-31 | $263 |
| 2023-09-30 | $235 |
| 2023-06-30 | $221 |
| 2023-03-31 | $285 |
| 2022-12-31 | $313 |
| 2022-09-30 | $283 |
| 2022-06-30 | $258 |
| 2022-03-31 | $205 |
| 2021-12-31 | $215 |
| 2021-09-30 | $204 |
| 2021-06-30 | $193 |
| 2021-03-31 | $197 |
| 2020-12-31 | $187 |
| 2020-09-30 | $179 |
| 2020-06-30 | $192 |
| 2020-03-31 | $186 |
| 2019-12-31 | $167 |
| 2019-09-30 | $156 |
| 2019-06-30 | $154 |
| 2019-03-31 | $152 |
| 2018-12-31 | $148 |
| 2018-09-30 | $141 |
| 2018-06-30 | $142 |
| 2018-03-31 | $144 |
| 2017-12-31 | $139 |
| 2017-09-30 | $124 |
| 2017-06-30 | $127 |
| 2017-03-31 | $132 |
| 2016-12-31 | $139 |
| 2016-09-30 | $110 |
| 2016-06-30 | $115 |
| 2016-03-31 | $114 |
| 2015-12-31 | $102 |
| 2015-09-30 | $102 |
| 2015-06-30 | $103 |
| 2015-03-31 | $103 |
| 2014-12-31 | $109 |
| 2014-09-30 | $96 |
| 2014-06-30 | $93 |
| 2014-03-31 | $92 |
| 2013-12-31 | $91 |
| 2013-09-30 | $87 |
| 2013-06-30 | $91 |
| 2013-03-31 | $90 |
| 2012-12-31 | $87 |
| 2012-09-30 | $78 |
| 2012-06-30 | $81 |
| 2012-03-31 | $79 |
| 2011-12-31 | $74 |
| 2011-09-30 | $68 |
| 2011-06-30 | $75 |
| 2011-03-31 | $77 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.731B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $240.247B | 28.55 |
| Intuitive Surgical (ISRG) | United States | $188.491B | 72.03 |
| IDEXX Laboratories (IDXX) | United States | $55.181B | 54.80 |
| Edwards Lifesciences (EW) | United States | $49.001B | 32.86 |
| IQVIA Holdings (IQV) | United States | $40.710B | 22.70 |
| Alcon (ALC) | Switzerland | $40.074B | 27.01 |
| Mettler-Toledo (MTD) | United States | $29.378B | 34.37 |
| DexCom (DXCM) | United States | $28.830B | 39.74 |
| STERIS (STE) | Ireland | $25.607B | 26.43 |
| Waters (WAT) | United States | $23.844B | 31.53 |
| Coloplast (CLPBY) | Denmark | $19.494B | 33.27 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.744B | 0.00 |
| Hologic (HOLX) | United States | $16.742B | 17.59 |
| Penumbra (PEN) | United States | $14.041B | 98.77 |
| Globus Medical (GMED) | United States | $12.667B | 26.58 |
| Glaukos (GKOS) | United States | $7.231B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.112B | 19.42 |
| TransMedics (TMDX) | United States | $4.719B | 55.91 |
| Teleflex (TFX) | United States | $4.644B | 7.40 |
| LivaNova (LIVN) | United Kingdom | $3.488B | 18.84 |
| Veracyte (VCYT) | United States | $3.462B | 39.46 |
| Integer Holdings (ITGR) | United States | $2.997B | 14.07 |
| Elekta AB (EKTAY) | Sweden | $2.473B | 23.14 |
| Alphatec Holdings (ATEC) | United States | $2.347B | 0.00 |
| Artivion (AORT) | United States | $2.081B | 95.48 |
| UFP Technologies (UFPT) | United States | $2.057B | 27.15 |
| Nihon Kohden (NHNKY) | Japan | $2.028B | 17.70 |
| PROCEPT BioRobotics (PRCT) | United States | $1.717B | 0.00 |
| AxoGen (AXGN) | United States | $1.476B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.396B | 0.00 |
| IRadimed (IRMD) | United States | $1.322B | 62.96 |
| OPKO Health (OPK) | United States | $1.044B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.986B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.950B | 5.14 |
| Pacific Biosciences Of California (PACB) | United States | $0.806B | 0.00 |
| SiBone (SIBN) | United States | $0.734B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.727B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.667B | 38.78 |
| Alpha Tau Medical (DRTS) | Israel | $0.608B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.608B | 12.13 |
| NeuroPace (NPCE) | United States | $0.568B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.548B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.477B | 13.18 |
| OrthoPediatrics (KIDS) | United States | $0.464B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.438B | 0.00 |
| RxSight (RXST) | United States | $0.405B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.404B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.388B | 64.59 |
| Sight Sciences (SGHT) | United States | $0.339B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Anteris Technologies Global (AVR) | Australia | $0.271B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.270B | 0.00 |
| 908 Devices (MASS) | United States | $0.253B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.203B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.195B | 0.00 |
| CVRx (CVRX) | United States | $0.172B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.171B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| Neuronetics (STIM) | United States | $0.151B | 0.00 |
| LENSAR (LNSR) | United States | $0.148B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.147B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.136B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.135B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.133B | 0.00 |
| Solana (HSDT) | United States | $0.133B | 0.00 |
| Hyperfine (HYPR) | United States | $0.121B | 0.00 |
| Accuray (ARAY) | United States | $0.094B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.085B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.082B | 0.00 |
| DarioHealth (DRIO) | United States | $0.079B | 0.00 |
| InspireMD (NSPR) | United States | $0.072B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.070B | 0.00 |
| Spectral AI (MDAI) | United States | $0.050B | 0.00 |
| Precision Optics (POCI) | United States | $0.039B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.030B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.016B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.011B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| ENvue Medical (FEED) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.74 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |